Dishman Carbogen Amcis Ltd

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated."

ACG is the world’s only integrated pharma manufacturing solutions company. Capsules + Films & Foils + Engineering + Inspection and Track & Trace systems, we do it all. Your global partners for end-to-end pharmaceutical solutions, no matter where you are.

ACG Worldwide has a presence in over 100 countries with its products and services, employing more than 3,200 members that strive to provide world-class technology across multiple domains. We offer a complete range of solutions beginning with empty capsules; granulation and tablet coating; capsule filling; tabletting; packaging films; blister packing and carton packing to the end-of-line solutions and track and trace systems. With over 20,000 machine installations worldwide, it speaks lengths of the high quality standards we follow at ACG as well as complying with major international quality certifications or legislation's.

For more than 60 years and 3 genarations, GYMA Laboratories has been the leading and trusted API supplier to the US pharmaceutical industry.

We’re proud that many of the pharmaceutical manufacturers who rely on our integrity, expertise, and follow-through have been with us for three, four, and even five decades.

As our industry has expanded over the last 15 years so has Gyma. Please read on to find out more about Gyma can do for you.

Our primary mission is to contribute to super-personalized medicine by providing platform technology on the immune system. There are huge issues as follows: drugs do not always have the desired effect and adverse drug events are among the leading causes of death. Approximately, half of global drug sales, corresponding to $500 billion per year, are wasted on ineffective treatments and more than 2.2 million severe adverse drug events occur each year in the United States including more than 100,000 deaths. By identifying each patient’s drug targets with our company’s two analysis platforms, which are immuno-profiling and somatic gene mutation analyses, we could appropriately combine existing standardized therapies and develop personalized therapies.

We believe that our detailed understanding of the immune system, particularly that of the behaviors of T and B cells and disease-specific mutations, is key to developing personalized medicine.

レパトア・ジェネシス株式会社は、T細胞/B細胞受容体レパトア解析、ネオエピトープ解析などを活用して、個別化医療につながる新しい診断法/治療法の実現を支援します。

当社のミッションは、免疫系のプラットフォーム技術を提供することで、高度なオーダーメイド医療に貢献することです。問題は山積しています。例えば、薬は必ずしも期待する効果をもたらすとは限らず、また薬剤による有害事象が主要な死因の1つになっています。世界の医薬品売上の約半分（年間5,000億ドル相当）は効果のない治療に浪費され、米国では毎年220万件以上の薬物有害事象が発生し、10万人以上が亡くなっています。当社が提供する2つの解析プラットフォーム（免疫プロファイリング分析、体細胞遺伝子突然変異解析）を利用して患者様一人ひとりの薬剤標的を同定すれば、既存の標準治療を適切に組み合わせて個別化治療を行うことができます。

当社は免疫系、なかでもT細胞やB細胞の行動や疾患特異的な突然変異に精通していますが、その知識がより効果的で効率的な医療を実現するためのカギになるはずです。

Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, that partners with our clients to support their vaccine and therapeutic development programs. We offer a unique combination of preclinical and clinical services designed to first address the scientific challenges often encountered during proof-of-concept, and then streamline process development and cGMP production of clinical supply.
ABL can assist with all aspects of production development including, but not limited to:
Basic and translational research
Vaccine and therapeutic product design
Animal models for preclinical evaluation including immunomonitoring , efficacy and potency
Cell line and process development
cGMP manufacture of cell banks and virus banks
cGMP manufacture of clinical supply for protein therapeutics, vaccines and live viral vectors

Ask about our 9,000 sq ft clinical GCLP immunomonitoring space and our vaccine and therapeutic testing services.

With a 50+ year history as a service provider to the life sciences industry, ABL brings a broad technical knowledge base, highly experienced work force, and seasoned project management to every program. Our goal is to become a seamless extension of our clients’ product development group – helping them advance today’s ideas into tomorrow’s medicines. Our history, capabilities and expertise allow ABL to provide solution based services to our clients.